US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist
  • 8.875
  • -0.125-1.39%
Trading Apr 24 12:29 ET
173.34MMarket Cap-6.35P/E (TTM)

About Actuate Therapeutics Company

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Company Profile

SymbolACTU
Company NameActuate Therapeutics
Listing DateAug 13, 2024
Issue Price8.00
Founded2015
CEOMr. Daniel M. Schmitt
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address1751 River Run,Suite 400
CityFort Worth
ProvinceTexas
CountryUnited States of America
Zip Code76107
Phone1-817-887-8455
Websitehttp://www.actuatetherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Daniel M. Schmitt
  • President, Chief Executive Officer and Director
  • 5.58M
  • Paul J. Lytle
  • Chief Financial Officer and Principal Accounting Officer
  • 1.90M
  • Dr. Andrew P. Mazar, PhD
  • Chief Operating Officer
  • 675.00K
  • Dr. Aaron G.L. Fletcher, PhD
  • Chairman of the Board
  • 124.31K
  • Amy L. Ronneberg
  • Independent Director
  • 213.11K
  • Todd S. Thon
  • Independent Director
  • 111.24K
  • Jason A. Keyes
  • Independent Director
  • 214.76K
  • Dr. Roger Sawhney, M.D.
  • Independent Director
  • 213.11K
  • Dr. Dan Zabrowski, PhD
  • Independent Director
  • 115.85K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
New Fortress Energy
NFE
5.735
DexCom
DXCM
70.305
Workday
WDAY
236.115
4
Teradata Corp
TDC
21.450
5
YETI Holdings
YETI
28.890
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀